109 related articles for article (PubMed ID: 21593221)
1. FDA approves prostate cancer treatment that inhibits testosterone synthesis.
Thompson CA
Am J Health Syst Pharm; 2011 Jun; 68(11):960. PubMed ID: 21593221
[No Abstract] [Full Text] [Related]
2. Abiraterone and increased survival in metastatic prostate cancer.
Berruti A; Pia A; Terzolo M
N Engl J Med; 2011 Aug; 365(8):766; author reply 767-8. PubMed ID: 21864182
[No Abstract] [Full Text] [Related]
3. Castration refractory prostate cancer: cinderella finally comes to the ball.
Chowdhury S; Harper P; Powles T
Onkologie; 2010; 33(12):655-6. PubMed ID: 21124035
[No Abstract] [Full Text] [Related]
4. Cabazitaxel.
Galsky MD; Dritselis A; Kirkpatrick P; Oh WK
Nat Rev Drug Discov; 2010 Sep; 9(9):677-8. PubMed ID: 20811375
[No Abstract] [Full Text] [Related]
5. Abiraterone and MVD3100 take androgen deprivation to a new level.
Schmidt C
J Natl Cancer Inst; 2011 Feb; 103(3):175-6. PubMed ID: 21242338
[No Abstract] [Full Text] [Related]
6. Expanding treatment options for metastatic prostate cancer.
Antonarakis ES; Eisenberger MA
N Engl J Med; 2011 May; 364(21):2055-8. PubMed ID: 21612475
[No Abstract] [Full Text] [Related]
7. [Abiraterone acetate: a novel therapeutic option in hormone-refractory prostate cancer].
Turitto G; Di Bisceglie M; Moraca L; Sasso N; Sepede C; Suriano A; Romito S
Recenti Prog Med; 2012 Feb; 103(2):74-8. PubMed ID: 22430753
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitors of the key enzymes of androgen synthesis: potential agents as targets for prostate cancer].
Takeda M; Hosaka M
Nihon Rinsho; 2000 Jul; 58 Suppl():312-6. PubMed ID: 11022738
[No Abstract] [Full Text] [Related]
9. US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun.
D'Amico AV
J Clin Oncol; 2014 Feb; 32(4):362-4. PubMed ID: 24344221
[No Abstract] [Full Text] [Related]
10. Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer.
Tagawa ST; Beltran H
Asian J Androl; 2011 Nov; 13(6):785-6. PubMed ID: 21857690
[No Abstract] [Full Text] [Related]
11. New prostate cancer drugs hold promise.
Cancer; 2013 Jan; 119(2):247-8. PubMed ID: 23292897
[No Abstract] [Full Text] [Related]
12. Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shore.
Goldkorn A; Aparicio AM; Quinn DI
Ann Oncol; 2013 Jul; 24(7):1717-1720. PubMed ID: 23798673
[No Abstract] [Full Text] [Related]
13. A new era for castrate resistant prostate cancer: a treatment review and update.
Fong MK; Hare R; Jarkowski A
J Oncol Pharm Pract; 2012 Sep; 18(3):343-54. PubMed ID: 22343966
[TBL] [Abstract][Full Text] [Related]
14. Abiraterone acetate is well tolerated without concomitant use of corticosteroids.
Attard G; Reid AH; de Bono JS
J Clin Oncol; 2010 Oct; 28(29):e560-1; author reply e562. PubMed ID: 20805462
[No Abstract] [Full Text] [Related]
15. Approval summary: Docetaxel in combination with prednisone for the treatment of androgen-independent hormone-refractory prostate cancer.
Dagher R; Li N; Abraham S; Rahman A; Sridhara R; Pazdur R
Clin Cancer Res; 2004 Dec; 10(24):8147-51. PubMed ID: 15623588
[TBL] [Abstract][Full Text] [Related]
16. Abiraterone: current and future use in prostate cancer.
Ryan CJ
Clin Adv Hematol Oncol; 2012 Mar; 10(3):180-1. PubMed ID: 22402426
[No Abstract] [Full Text] [Related]
17. Abiraterone acetate.
Logothetis CJ; Efstathiou E; Manuguid F; Kirkpatrick P
Nat Rev Drug Discov; 2011 Aug; 10(8):573-4. PubMed ID: 21804589
[No Abstract] [Full Text] [Related]
18. Prostate cancer hope.
Wallis L
Nurs Stand; 2008 Oct 8-14; 23(5):21. PubMed ID: 18947077
[TBL] [Abstract][Full Text] [Related]
19. New prostate cancer drug: Prostate cancer's day in the sun.
Attard G; Reid AH; Dearnaley D; De Bono JS
BMJ; 2008 Aug; 337():a1249. PubMed ID: 18694888
[No Abstract] [Full Text] [Related]
20. The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature.
Sonpavde G; Attard G; Bellmunt J; Mason MD; Malavaud B; Tombal B; Sternberg CN
Eur Urol; 2011 Aug; 60(2):270-8. PubMed ID: 21550166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
